Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 93 (5), 664-668
- https://doi.org/10.1016/j.amjcard.2003.11.046
Abstract
Xanthine oxidase contributes to oxidant stress and has been proposed as a risk factor for endothelial dysfunction. We studied the role of xanthine oxidase in conduit artery endothelial dysfunction in 12 smokers and 12 controls. Conduit artery vasodilation was impaired in smokers (4.3%) compared with controls (7.9%) (p = 0.006) and improved with xanthine oxidase inhibition in smokers (9.2%, p <0.001).Keywords
This publication has 16 references indexed in Scilit:
- Xanthine Oxidase–Derived Reactive Oxygen Species Convert Flow-Induced Arteriolar Dilation to Constriction in HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Serum Uric Acid and Cardiovascular MortalityJAMA, 2000
- Nitrosation of Uric Acid by PeroxynitritePublished by Elsevier BV ,1998
- Xanthine Oxidase Inhibition With Oxypurinol Improves Endothelial Vasodilator Function in Hypercholesterolemic but Not in Hypertensive PatientsHypertension, 1997
- Antioxidant Vitamin C Improves Endothelial Dysfunction in Chronic SmokersCirculation, 1996
- Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjectsBritish Journal of Clinical Pharmacology, 1996
- Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.Circulation, 1993
- Uric acid as radical scavenger and antioxidant in the heartPflügers Archiv - European Journal of Physiology, 1989
- Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.British Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of AllopurinolClinical Pharmacokinetics, 1986